FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
TPG RE Finance Trust, Inc. Declares Cash Dividend on Common Stock
GRAL Breaking News: GRAIL, Inc. Sued for Securities Fraud after Trial Results Lead to 50% Stock Drop – Investors Notified to Contact BFA Law
Savara Inc. - Savara Announces New Employment Inducement Grant
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
4DMT Announces New Employment Inducement Grants
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Canterbury Park Holding Corporation Announces Quarterly Cash Dividend
Irenic Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing June 18, 2026
Cartesian Therapeutics Announces New Employment Inducement Grant